An alternative effector gene at the type 2 diabetes-associated TCF7L2 locus? by van de Bunt, M

From genetic association to molecular mechanism. by van de Bunt, M, Gloyn, A

A tale of two glucose transporters: How GLUT2 re-emerged as a contender for glucose transport into the human beta cell by Van De Bunt, M, Gloyn, A

A tale of two glucose transporters: how GLUT2 re-emerged as a contender for glucose transport into the human beta cell. by van de Bunt, M, Gloyn, A

Monogenic disorders of the pancreatic β-cell: Personalizing treatment for rare forms of diabetes and hypoglycemia by van de Bunt, M, Gloyn, A

Gene duplications resulting in over expression of glucokinase are not a common cause of hypoglycaemia of infancy in humans. by van de Bunt, M, Edghill, E, Hussain, K, Ellard, S, Gloyn, A

Insights into β-cell biology and type 2 diabetes pathogenesis from studies of the islet transcriptome by Van De Bunt, M, Morán, I, Ferrer, J, McCarthy, M

Glucokinase (GCK) and other susceptibility genes for beta-cell dysfunction: the candidate approach. by Gloyn, A, Tribble, N, van de Bunt, M, Barrett, A, Johnson, P

A multi-tissue transcriptome analysis of human metabolites guides interpretability of associations based on multi-SNP models for gene expression by Ndungu, A, Payne, A, Torres, J, Van De Bunt, M, McCarthy, M

Prevalence of GCK mutations in individuals screened for fasting hyperglycaemia. by Gloyn, A, van de Bunt, M, Stratton, I, Lonie, L, Tucker, L, Ellard, S, Holman, R

GLUT2 (SLC2A2) is not the principal glucose transporter in human pancreatic beta cells: implications for understanding genetic association signals at this locus. by McCulloch, L, van de Bunt, M, Braun, M, Frayn, K, Clark, A, Gloyn, A

Prevalence of glucokinase (GCK) mutations in people with elevated fasting glucose levels: implications for clinical trials by Gloyn, A, van de Bunt, M, Stratton, I, Tucker, L, Lonie, L, Ellard, S, Holman, R

Mutations in HHEX are not a common cause of monogenic forms of beta cell dysfunction. by Minton, J, van de Bunt, M, Boustred, C, Hussain, K, Hattersley, A, Ellard, S, Gloyn, A

GLUT2 (SLC2A2) is not the principal glucose transporter in human pancreatic beta cells: Implications for understanding genetic association signals at this locus by McCulloch, L, van de Bunt, M, Braun, M, Frayn, K, Clark, A, Gloyn, A

SSTR2 is the functionally dominant somatostatin receptor in human pancreatic β- and α-cells. by Kailey, B, van de Bunt, M, Cheley, S, Johnson, P, MacDonald, P, Gloyn, A, Rorsman, P, Braun, M

Discovery of a novel site regulating glucokinase activity following characterization of a new mutation causing hyperinsulinemic hypoglycemia in humans. by Beer, N, van de Bunt, M, Colclough, K, Lukacs, C, Arundel, P, Chik, C, Grimsby, J, Ellard, S, Gloyn, A

Insights into islet development and biology through characterization of a human iPSC-derived endocrine pancreas model by van de Bunt, M, Lako, M, Barrett, A, Gloyn, A, Hansson, M, McCarthy, M, Beer, N, Honoré, C

Large-scale integrated genome-wide RNA sequencing, miRNA array, and genomic analyses to unravel the functionality of genome-wide association results in endometriosis by Rahmioglu, N, Lockstone, H, Ferreira, T, Magi, R, Van De Bunt, M, Lindgren, C, Morris, A, Becker, C, Zondervan, K

Systematic Functional Characterization of Candidate Causal Genes for Type 2 Diabetes Risk Variants by Thomsen, S, Ceroni, A, van de Bunt, M, Burrows, C, Barrett, A, Scharfmann, R, Ebner, D, McCarthy, M, Gloyn, A

Patterns of differential gene expression in a cellular model of human islet development, and relationship to type 2 diabetes predisposition by Perez-Alcantara, M, Honoré, C, Wesolowska-Andersen, A, Gloyn, A, McCarthy, M, Hansson, M, Beer, N, van de Bunt, M